Enhance your nephrology practice with CME and tools focused on kidney medicine.
Differentiating Oral Potassium Binders: Mechanism, Onset, and Sodium Load
James Burton, DM, FRCP
Ellie Kelepouris, MD, FACP, FAHA
Personalized Treatment Strategies for Hyperkalemia: Bridging Evidence and Clinical Practice Needs
Potassium Binders to Optimize GDMT Therapy in HFrEF
Nihar R. Desai, MD, MPH
The Edema Question: Selecting a Potassium Binder in Patients With HF or Congestion
Pauline A. Swift, PhD
The Hidden Danger of IgAN: Pathogenesis and Unmet Needs
Jonathan Barratt, MD, PhD
Proteinuria in IgAN: The Signal, The Target, and the Treatment Goal
An De Vriese, MD, PhD
Decoding IgA Nephropathy: From Suspicion to Solution
Chee Kay Cheung, MBChB, MRCP, PhD
Jörg Latus, MD
Translating Evidence into IgAN Care
The Potassium Shift: Individualizing Hyperkalemia Management With Modern Oral Potassium Binders
The Binder Selection Playbook: Matching the Right Strategy to the Right Patient
The Evolving Role of Biomarkers in IgAN
The Future of IgAN Care
Mechanisms Matter! Optimizing Proteinuria Reduction In IgAN
Engaging Patients With Heart Failure and Chronic Hyperkalemia: Shared Decision-Making to Support Guideline-Directed Medical Therapy
Gianluigi Savarese, MD, PhD, FESC, FHFA
CKD-aP Uncovered Prevalence & Pathophysiology
Steven Fishbane, MD
Nancy Helou, PhD
Spotlight on Assessment: Tools That Capture CKD-aP
Federico Alberici, MD, PhD
Anastasia Liossatou, PhD, RN
Hyperkalemia as a Barrier to GDMT: Why “Stopping GDMT” Is Often the Wrong Reflex
From Lab Alert to Action Plan: Monitoring Potassium Without Undermining Cardiorenal Protection
Unmasking IgAN: Achieving Earlier Diagnosis
From Scratch to Strategy: Talking About CKD-aP in Clinical Practice
Reading Between the Lines: What PROMs Reveal About Itch
Translating the Latest KDIGO Guidelines Into Practice: IV Iron Therapy in Patients With Non–Dialysis-Dependent CKD
Patrick Rossignol, MD, PhD
Julio Núñez, MD, PhD
Navigating KDIGO Practice Guideline Recommendations to Maximize Proteinuria Reduction in Patients With IgAN
Claudia Seikrit, MD
Optimizing Iron Deficiency Management in CKD: IV Iron Replacement Therapy Amid the Latest KDIGO Guidelines
Brendon Neuen, MBBS, PhD
Loading...
NEW FEATURES:
Tell us what you think by using our Feedback button
We're glad to see you're enjoying Global Kidney Academy… but how about a more personalized experience?
Press cancel to remain on Global Kidney Academy. Press the link below or the continue button to keep going.